SARS-CoV-2 (COVID-19) Nucleocapsid Antibody (IN) | 10-509

SARS-CoV-2 (COVID-19) Nucleocapsid Antibody (IN) | 10-509 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Virus

Homology: N/A

Immunogen: Synthetic peptide located within the center of SARS-CoV-2 (COVID-19) Nucleocapsid.

Research Area: Infectious Disease, COVID-19

Tested Application: E, WB

Application: WB: 1:500-1000

Specificiy: N/A

Positive Control 1: N/A

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: N/A

Validation: N/A

Isoform: N/A

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE) .

Clonality: Polyclonal

Clone: N/A

Isotype: IgG

Conjugate: Unconjugated

Physical State: Liquid

Buffer: PBS with 0.02% sodium azide, 10% glycerol, pH7.2

Concentration: batch dependent

Storage Condition: Store at 4˚C short term. Aliquot and store at -20˚C long term. Avoid freeze-thaw cycles.

Alternate Name: SARS-CoV-2 (COVID-19, 2019-nCoV) Nucleocapsid Antibody: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) , Nucleocapsid Phosphoprotein, Nucleocapsid protein

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: N/A